ArticleAnnals of translational medicine2020

Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.

Fengrui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.